Article
HGUE-C-1 is an atypical and novel colon carcinoma cell line.
BMC cancer - 8 Apr 2015
Grasso Silvina, Martínez-Lacaci Isabel, Barberá Víctor Manuel, Castillejo Adela, Soto José Luis, Gallego-Plazas Javier, López-Riquelme Natividad, García-Morales Pilar, Mata-Balaguer Trinidad, Ferragut José Antonio, Saceda Miguel
Abstract excerpt
BACKGROUND: Colorectal carcinoma is a common cause of cancer. Adjuvant treatments include: 5-fluorouracil administered together with folinic acid, or more recently, oral fluoropyrimidines such as capecitabine, in combination with oxaliplatin or irinotecan. Metastatic colorectal cancer patients can benefit from other additional treatments such as cetuximab or bevacizumab. METHODS: Using cell culture techniques, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
